Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update
LIVE QUOTE
Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine)
Scheduled to Initiate During the Second Half of This Year
ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE)...
Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate Lurks.
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Click to...
Report: AI Powered Review on GeoVax (GOVX) $1.15
In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC...
Adding Cabaletta (CABA) $3.07, GeoVax (GOVX) $1.14, PolyPid (PYPD) $4.68 and Replimune (REPL) $2.17...
Biotech 12 Pack Watch List to be Released.
Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Added to Watch List.
In 2020, we Released...
Replimune (REPL). $269 Million in Cash and a $178 Million Market Cap. What are...
Adding Replimune to 2026 Watch List @ $2.17
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but...
GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
Adding Oncolytics Biotech Inc. (ONCY) $1.02 to 2025 Watch List.
The Oncolytics Biotech Inc. (ONCY) idea is coming from one of our top 'tipsters' the Big Wig - whose two previous ideas, Allarity (ALLR)...
Latest article
Fairchild Gold (FAIR.V) Advances Towards Drilling.
Fairchild Gold Advances Toward Drilling at Nevada Titan as Geophysics Sharpens Porphyry Targeting
Vancouver, British Columbia and Las Vegas, Nevada--(Newsfile Corp. - August 21, 2026)...
Hecla Mining (HL) $20.75 – Rips 33% Higher, on Incredible Numbers.
Shareholders Celebrate $4 Billion Gain in Market Value, in a Couple Weeks! And we'll drink to that!
When we added Hecla Mining (HL) to the...
A Turnaround at Mitesco Coming? Mitesco Moves Into Mini-Data Centers.
Last Round (turnaround that is) worked great, back in 2019, Trading From $0.02 to $0.50. And no, we Didn't Sell a Single Share (waa)....
